Glutamine
Conditionally essential amino acid (L-glutamine)
Glutamine is genuinely the preferred fuel of intestinal cells, but that mechanism has not translated into demonstrated benefit for gut health in healthy people. Some evidence supports its use in specific clinical settings; there is no good evidence for routine supplementation, and 'leaky gut syndrome' is not a recognised diagnosis.
How confident is BioSignal?
Our overall position, and how sure we are of it across each dimension — including where we are not sure at all.
Limited evidence
Glutamine is genuinely the preferred fuel of intestinal cells, but that mechanism has not translated into demonstrated benefit for gut health in healthy people. Some evidence supports its use in specific clinical settings; there is no good evidence for routine supplementation, and 'leaky gut syndrome' is not a recognised diagnosis.
Early or sparse human evidence; conclusions remain uncertain.
Biological Role
Glutamine is the most abundant free amino acid in the body and the primary energy substrate for enterocytes. This part of the story is entirely true — and it is where the rest of the story overreaches.
Human Evidence
Trials in healthy adults are few and unimpressive. The better evidence sits in clinical nutrition — critical illness, short bowel syndrome, post-infectious IBS — where results are still mixed.
Supplement Benefit
No demonstrated benefit for gut health, digestion, or intestinal permeability in healthy adults. Being non-deficient in something is a poor reason to supplement it.
Broader Claims
Claims for immunity, muscle growth, and recovery are weak. Glutamine was extensively studied in sports nutrition and largely failed to deliver.
Safety Confidence
Well tolerated in healthy people at typical doses. Genuine caution is warranted in liver disease and in critical illness, where a large trial found harm.
Research Activity
Active in clinical nutrition and intestinal-permeability research; commercially active far out of proportion to the supporting evidence.
Where the evidence stands today
How mature the science is, what kinds of evidence exist, and — the part nobody else prints — what is still missing.
3/9
steps proven in humans
Partly established
2 steps not demonstrated: Clinical outcomes · Guideline / regulatory support
Guideline / regulatory support
Not shownNot recommended for gut health.
Clinical outcomes
Not shownNo demonstrated gut-health outcome in healthy adults.
Large human RCTs
LimitedThe major trial (critical illness) showed harm, not benefit.
Small human outcome trials
LimitedPost-infectious IBS signal; needs replication.
Human safety data
LimitedGood in health; increased mortality in critical illness.
Human biomarker / pharmacology
LimitedPermeability marker changes of unclear clinical significance.
Animal
ProvenIntestinal repair models.
Cell / in vitro
ProvenBarrier-function and enterocyte studies.
Mechanistic plausibility
ProvenThe primary fuel of intestinal cells — established.
The bottom line
What we know, what we think, what we don't know — and what would change our mind.
What We Know
Glutamine really is the main fuel for the cells lining your gut, and it really is 'conditionally essential' — meaning the body may not make enough during severe physiological stress such as major trauma, burns, or critical illness.
What We Think
That mechanism does not translate to healthy people. The body produces glutamine in large quantities, healthy adults are not deficient, and supplementing a nutrient you already have enough of rarely does anything.
What We Don't Know
Whether glutamine meaningfully changes intestinal permeability in humans in a way that matters clinically. Permeability is a real research phenomenon — but 'leaky gut syndrome' as a diagnosable disease that glutamine treats is not a recognised clinical entity.
Active Research
Clinical nutrition in short bowel syndrome, post-infectious IBS, chemotherapy-related mucositis, and the genuine science of intestinal barrier function.
What Could Change Our Mind
Trials in healthy or IBS populations showing that glutamine improves a clinical outcome — not a permeability marker. Markers are not outcomes.
The biggest myth
“Glutamine cures 'leaky gut syndrome'”
'Leaky gut syndrome' is not a recognised medical diagnosis. Intestinal permeability is a genuine, measurable phenomenon associated with several diseases, but it has not been established as a treatable condition in itself — nor that glutamine fixes it, nor that doing so would improve health.
Ask BioSignal
Still have a question about glutamine?
Answers are retrieved from this record and the rest of the knowledge graph — never generated.
Why people take glutamine
Popularity is not evidence — but it is not stupid either. This explains the interest on its own terms.
Glutamine is the anchor of the 'gut repair' and 'leaky gut' supplement category — a category built on one true fact (it feeds gut cells) and one unproven leap (that you need more of it). It is the clearest case in the gut ecosystem of a real mechanism sold as a real benefit.
If you're here because…
Jump straight to the part of the evidence that answers your question.
Approval, safety and regulatory
What it is approved for, who should be careful, what remains unknown — and the limits of what this evidence can tell you.
Regulatory status
Not an approved drug for gut health (dietary supplement). A glutamine product is approved for sickle cell disease — an unrelated indication
Availability
Over-the-counter supplement
Sport (WADA)
Not a prohibited class (confirm at publication)
Known safety profile
Glutamine is generally well tolerated by healthy people at typical supplemental doses. The important safety signal comes from the clinical setting, not the supplement aisle.
Common issues
- Occasional gastrointestinal upset
- Bloating at higher doses
Use caution if
- Critically ill patients (a large trial found increased mortality with high-dose glutamine)
- People with liver disease or cirrhosis (impaired ammonia handling)
- People with kidney impairment
- People with a history of seizures (theoretical, via glutamate)
- People who are pregnant or breastfeeding (limited data)
Long-term unknowns
The effects of prolonged supplementation in healthy people are not well characterised — again, largely because no benefit has been established that would justify the study.
Limits of this evidence
The gap between mechanism and outcome is unusually wide here. Glutamine's biology is genuinely compelling, which is what makes it such a useful cautionary tale: the critical-illness trial showed that a plausible mechanism, confidently applied, can cause harm rather than benefit.
Full regulatory and sport detail
- Regulatory approval
- Not FDA-approved as a drug for gut health; sold as a dietary supplement. A prescription glutamine product is approved for sickle cell disease, which is unrelated to the gut-health claims.
- Approved indication
- None for gut health.
- Research chemical
- N/A — a widely available amino acid.
- Sport (WADA)
- Not a WADA-prohibited class — confirm against the current list.
- Publication note
- Re-confirm regulatory status against primary sources at publication.
Demand, separated from evidence
Every claim people make about this, counted against what the evidence actually showed.
BioSignal evaluated 8 popular claims about glutamine.
Here is where each one landed — including the claims of harm, where “not established” is reassuring rather than damning.
- Supported by evidence
- 1
- Mixed evidence
- 2
- Insufficient evidence
- 1
- Not established
- 4
Popularity is not evidence. This is simply a count of every claim BioSignal evaluated on this page, sorted by what the evidence actually showed — the full reasoning behind each verdict is in the Evidence Review below.
Supported by evidence
- Glutamine is the primary fuel for intestinal cells
Mixed evidence
- Glutamine helps post-infectious IBS
- Glutamine reduces chemotherapy-related mucositis
Insufficient evidence
- Glutamine boosts immunity
Not established
- Glutamine cures 'leaky gut syndrome'
- Glutamine improves gut health in healthy adults
- Glutamine is beneficial in critical illness
- Glutamine builds muscle or improves exercise recovery
The evidence review
Every claim with the reasoning behind its verdict, the doses actually studied, where scientists agree and disagree, and the questions still open.
What people claim
Every popular claim, with BioSignal’s verdict and how confident we are in it. The verdicts are always visible; open any claim to read the evidence behind it.
Glutamine is the primary fuel for intestinal cellsSupportedHigh confidence
Established physiology. Enterocytes preferentially use glutamine as an energy source. This is the true premise from which most of the unsupported claims are extrapolated.
Glutamine improves gut health in healthy adultsNot establishedModerate confidence
No good evidence supports this. Healthy people are not glutamine-deficient, and supplementation has not demonstrated benefit for digestion or gut function in this group.
Glutamine helps post-infectious IBSMixedLimited evidence
A randomised trial in IBS-D following gastroenteritis reported meaningful symptom improvement. This is the most interesting human signal for glutamine in gut disease, but it is a narrow population and needs replication.
Glutamine is beneficial in critical illnessNot establishedModerate confidence
This was once standard practice, but a large randomised trial in critically ill patients found increased mortality with high-dose glutamine. The story reversed — and it is a valuable reminder that plausible mechanisms can be actively harmful.
Glutamine builds muscle or improves exercise recoveryNot establishedModerate confidence
Glutamine was heavily marketed in sports nutrition and studied extensively. It does not meaningfully increase muscle mass or strength in healthy trained individuals.
Glutamine boosts immunityInsufficient evidenceLimited evidence
Immune cells do use glutamine, and it may matter in catabolic clinical states. There is no good evidence that supplementation improves immune function in healthy people.
Glutamine reduces chemotherapy-related mucositisMixedLimited evidence
Studied in oncology supportive care with inconsistent results. This is a clinical, supervised use — not a reason for general supplementation.
Doses used in human studies
What was actually given to participants in the research. These are descriptions of studies, not recommendations.
Adults with post-infectious IBS-D (trial)
- Intervention
- Oral L-glutamine
- Dose
- ~15 g/day (5 g three times daily)
- Duration
- 8 weeks
- Outcome
- IBS symptom severity
- Notes
- A randomised trial in this specific population reported benefit; requires replication
Short bowel syndrome (clinical)
- Intervention
- Glutamine as part of clinical nutrition support
- Dose
- Clinician-directed
- Duration
- Clinician-directed
- Outcome
- Intestinal adaptation and nutrient absorption
- Notes
- A supervised medical use; results are mixed
Critically ill patients
- Intervention
- High-dose glutamine supplementation
- Dose
- High-dose (as tested)
- Duration
- During critical illness
- Outcome
- Mortality
- Notes
- A large randomised trial found INCREASED mortality. Recorded here as a caution, not a protocol
Healthy adults
- Intervention
- Oral glutamine for 'gut health'
- Dose
- Commonly ~5 g/day in products
- Duration
- Indefinite in practice
- Outcome
- No demonstrated clinical outcome
- Notes
- No dose is established because no benefit is established in this group
Where scientists agree — and don’t
Agreed
- Glutamine is the preferred energy substrate of intestinal cells.
- It is conditionally essential — the body's own production may be insufficient in severe physiological stress.
- Healthy adults are not glutamine-deficient.
- 'Leaky gut syndrome' is not a recognised clinical diagnosis.
Debated
- Whether glutamine has a genuine role in post-infectious IBS.
- Its value in short bowel syndrome and clinical nutrition.
- The clinical significance of measured changes in intestinal permeability.
Unknown
- Whether supplementation changes intestinal permeability in humans in any way that matters.
- Why a mechanistically compelling nutrient has repeatedly failed to deliver clinical benefit.
- Whether any healthy population benefits at all.
What remains unknown
- Does the post-infectious IBS finding replicate in larger, independent trials?
- Is intestinal permeability a cause of disease, a consequence of it, or a bystander?
- Why did high-dose glutamine increase mortality in critical illness despite a plausible mechanism?
- Does supplementation do anything measurable in a healthy, well-fed adult?
Questions people actually ask
What is glutamine?
Glutamine is the most abundant free amino acid in the body and the preferred fuel of the cells lining the intestine. It is 'conditionally essential', meaning your body normally makes plenty, but may not make enough during severe stress such as major burns, trauma, or critical illness.
Does glutamine fix 'leaky gut'?
'Leaky gut syndrome' is not a recognised medical diagnosis, so there is no established condition for glutamine to fix. Intestinal permeability is a real, measurable phenomenon that scientists study and that accompanies several diseases — but whether it causes those diseases, and whether changing it helps, is unresolved. The supplement category is built on a certainty that the science has not reached.
Should I take glutamine for my gut?
If you are a healthy adult, there is no good evidence it will do anything. You are not deficient, your body makes it in quantity, and supplementing a nutrient you already have enough of is rarely useful. If you have IBS that began after a bout of gastroenteritis, there is one interesting trial — worth discussing with a clinician, not a reason for confidence.
Is glutamine safe?
For healthy people at typical doses, it is well tolerated. But the critical illness story is a genuine caution: a large trial found that high-dose glutamine increased mortality in critically ill patients. It should also be used carefully in liver disease. 'It's just an amino acid' is not the same as 'it's harmless in every context'.
Doesn't it work because gut cells run on glutamine?
That is exactly the argument, and it is exactly where it breaks down. Gut cells do run on glutamine — but they already have all they need. A car runs on petrol; that does not mean adding petrol to a full tank makes it go faster. A true mechanism is not, by itself, evidence of benefit.
Practical takeaways
- Glutamine genuinely is the main fuel for gut lining cells — and that fact has been stretched a very long way.
- Healthy people are not deficient, and supplementation has no demonstrated gut-health benefit.
- 'Leaky gut syndrome' is not a recognised diagnosis, however real intestinal permeability is as a research topic.
- The most interesting signal is in post-infectious IBS — a narrow population, needing replication.
- High-dose glutamine increased mortality in critically ill patients: plausible mechanisms can still cause harm.
How it works
The mechanism comes last on purpose. A compelling explanation of how something might work is the easiest part of the story to tell, and the part most likely to outlive the evidence for it.
Glutamine is the most abundant free amino acid in the body and the primary energy substrate for enterocytes. This part of the story is entirely true — and it is where the rest of the story overreaches.
How we found out
Established Physiology
Glutamine was characterised as the most abundant free amino acid in the body and the preferred fuel of intestinal cells — genuine, uncontroversial science.
The Clinical Nutrition Era
Glutamine supplementation became widespread in critical care and clinical nutrition, on the strength of its mechanism and the concept of conditional essentiality.
The Critical Illness Reversal
A large randomised trial found increased mortality with high-dose glutamine in critically ill patients, overturning established practice and demonstrating that mechanistic plausibility is not a safety guarantee.
The 'Leaky Gut' Commercial Era
Glutamine became the anchor ingredient of gut-repair supplements marketed for 'leaky gut syndrome' — a condition that is not a recognised diagnosis — even as the clinical evidence moved in the opposite direction.
References
Verified sources. BioSignal does not print a citation it has not checked.
References for this record are being verified and will be published with the next review. BioSignal does not print citations it has not checked.
Version history
Version 1.0
Initial record for the Gut Ecosystem, authored to the Creatine benchmark. Calibration: Emerging maturity, limited confidence. The critical-illness harm signal is recorded prominently, and 'leaky gut syndrome' is addressed directly rather than sidestepped. Review cadence: Annually.
Continue exploring
Three places this record leads next.